PHACOEMULSIFICATION DEVICES MARKET

KEY FINDINGS

• The anticipated growth drivers for the phacoemulsification devices market include the rising incidence of cataracts and the expanding elderly population on a global scale. 
• Market growth is driven by the advantages of phacoemulsification devices, including smaller incisions, rapid recovery, outpatient treatment, reduced complications, and early visual improvement. 
• Additionally, the absence of activity limitations and reduced astigmatism due to smaller incisions have led to widespread adoption of phacoemulsification for cataract surgery. 
• Global cataract incidence is rising sharply, with about 18 million people suffering from bilateral blindness, driven by aging, diabetes, and smoking. However, increasing awareness and early treatment initiatives in emerging nations are expected to fuel phacoemulsification device market growth. 
• North America is poised to dominate market revenue due to extensive research, increasing patient numbers, and high disposable incomes driving the region's market share. 
• Europe's substantial market share is anticipated due to rising cataract cases, heightened treatment awareness, and a growing elderly demographic. 
• Asia Pacific's market is forecasted to grow significantly, driven by a large patient base, government initiatives to curb visual impairment, and increased investments by key players, especially in India and China. 
• Additionally, leading market players like Johnson & Johnson produce consumables such as phacoemulsification foot pedals, handpieces, and packs, thereby stimulating segment growth and consequently driving market expansion in the forecast period. 
• Innovations in phacoemulsification systems by key companies, coupled with new device launches, collaborations, and business expansion efforts, are anticipated to drive growth in this segment. 

PHACOEMULSIFICATION DEVICES MARKET INTRODUCTION

The internal lens of the eye is emulsified with an ultrasonic handpiece and aspirated from the eye during phacoemulsification, a contemporary technique for performing cataract surgery. To keep the anterior chamber functioning, aspirated fluids are replenished by irrigation of a balanced salt solution. Ocular surgery requires the right anesthetic. Most frequently, local anesthetics like lidocaine or tetracaine are injected into a treatment area to provide topical anesthesia.

As an alternative, to more completely immobilize the extraocular muscles and lessen pain perception, lidocaine and/or longer-acting bupivacaine anesthetic may be administered into the region around or beyond the eye muscle cone (peribulbar block) or behind the eye (retrobulbar block).

Sometimes, lid squeezing can be lessened by performing a facial nerve block with lidocaine and bupivacaine. Children, adults with cataracts from trauma to the eyes, severely frightened or reluctant patients, and animals should all be under general anesthesia. Cardiovascular monitoring is advised when receiving local anesthetic, and it is required when receiving general anesthesia.

The surgical site is cleaned and sterilized properly, and antiseptics like povidone-iodine are used to prevent infection. It is common to use sterile gloves, gowns, and drapes. The fluids are collected during phacoemulsification using a plastic sheet with a receptacle. To maintain open eyelids, an eye speculum is placed.

One or more incisions are created in the eye to allow the entrance of surgical tools prior to the phacoemulsification procedure. The anterior face of the capsule containing the lens inside the eye is then removed by the surgeon. During phacoemulsification surgery, a device with microprocessor-controlled fluid dynamics is used. These can be built using a venturi or peristaltic kind of pump.

PHACOEMULSIFICATION DEVICES MARKET SIZE AND FORECAST

The Global Phacoemulsification Devices Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

PHACOEMULSIFICATION DEVICES MARKET NEW PRODUCT LAUNCH

In order to give surgeons more comfort and efficiency during cataract surgery, Johnson & Johnson (J&J) Vision has launched its phacoemulsification devices on a global scale. Phacoemulsification, the form of cataract surgery that is most frequently used, enables doctors to emulsify and remove the internal lens of the eye when it develops cataracts and becomes hazy.

The method makes use of J&J's WHITESTAR technology combined with elliptical tip movement for smoother cutting, even in thick or advanced cataracts. With less energy, lenses may be extracted more successfully because to this.

PHACOEMULSIFICATION DEVICES MARKET NEW PRODUCT DEVELOPMENT

PHACOEMULSIFICATION DEVICES MARKET COMPANY PROFILES

• Johnson & Johnson
• HOYA
• Lensetec
• Medical Technical
• SIFI
• Alcon
• Glaukos Corp. 
• Halma Plc 
• HumanOptics Holding AG

PHACOEMULSIFICATION DEVICES MARKET REPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many Phacoemulsification Devices are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of Global Phacoemulsification Devices and key vendor selection criteria
3. Where are the Phacoemulsification Devices manufactured? What is the average margin per unit?
4. Market share of Global Phacoemulsification Devices market  manufacturers and their upcoming products
5. The cost advantage for OEMs who manufacture Global Phacoemulsification Devices in-house
6. key predictions for the next 5 years in the Global Phacoemulsification Devices market
7. Average B-2-B Phacoemulsification Devices market price in all segments
8. Latest trends in the Phacoemulsification Devices market, by every market segment
9. The market size (both volume and value) of the Phacoemulsification Devices market in 2024-2030 and every year in between?
10. Production breakup of the Phacoemulsification Devices market, by suppliers and their OEM relationship